OMB Number:

February 28, 2022

Estimated average burden hours per response



Washington, D.C. 20549

FORM 12b-25


(Check one):    ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K x Form 10-Q
☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR

For Period Ended: June 30, 2020

☐ Transition Report on Form 10-K
☐ Transition Report on Form 20-F
☐ Transition Report on Form 11-K
☐ Transition Report on Form 10-Q

For the Transition Period Ended:
Read Instructions (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to the portion of the filing checked above, identify the item(s) to which the notification relates:


Flotek Industries, Inc.
Full Name of Registrant

Former Name if Applicable

8846 N. Sam Houston Pkwy W.
Address of Principal Executive Office (Street and Number)

Houston, Texas 77064
City, State and Zip Code

(Not applicable)
(Former name or former address, if changed since last report.)

PART II - RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
The reason described in reasonable detail in Part III of this form could not be limited without unreasonable effort or expense.
The subject annual report, semi-annual report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form NCSR, or portion thereof, will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
The accountant's statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.


State below in reasonable details why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR or the transition report or portion thereof, could not be filed within the prescribed time period. (Attach extra Sheets if Needed).

Flotek Industries, Inc. (the "Company") is filing this Form 12b-25 because it has determined that it is unable to file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2020 (the "Form 10-Q") within the prescribed time period without unreasonable effort or expense for the reasons set forth below.

In the course of preparing the financial statements for the Form 10-Q, an error was discovered that may require adjustments to previously issued financial statements related to the classification of proceeds received from the sale of Florida Chemical Company to Archer-Daniels-Midland in February 2019 and related escrow account on the statements of cash flows. The Company is working diligently to complete its review of the matter, take any remedial action, and file the Form 10-Q by August 17, 2020.

Forward Looking Statements

Certain statements set forth in this Form 12b-25 constitute forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) regarding Flotek Industries, Inc.’s business, financial condition, results of operations and prospects. Words such as will, may, continue, expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements, but are not the exclusive means of identifying forward-looking statements in this press release.  Although forward-looking statements in this Form 12b-25 reflect the good faith judgment of management, such statements can only be based on facts and factors currently known to management.  Consequently, forward-looking statements are inherently subject to risks and uncertainties, including, for example, the timing of the filing of the Form 10-Q or other SEC filings, and actual results and outcomes may differ materially from the results and outcomes discussed in the forward-looking statements.  Further information about the risks and uncertainties that may impact the Company are set forth in the Company’s most recent filing with the Securities and Exchange Commission on Form 10-K (including, without limitation, in the "Risk Factors" section thereof), and in the Company’s other SEC filings and publicly available documents.  Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Form 12b-25.


(1)    Name and telephone number of person to contact in regard to this notification

Michael Borton
(Area Code)
(Telephone Number)

Have all other period reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify reports. x Yes ☐ No

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? x Yes ☐ No

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

On August 5, 2020, the Company issued an earnings press release with respect to the fiscal quarter ended June 30, 2020 and announcing the anticipated delay in filing the Form 10-Q and included a copy of such press release in its Current Report on Form 8-K furnished to the Securities and Exchange Commission on August 6, 2020.  Certain information about the Company’s financial results for the fiscal quarter ended June 30, 2020 compared to the comparable prior year period is included in such earnings release.

(Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

Date: August 10, 2020
/s/ Michael Borton
Michael Borton
Chief Financial Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.

Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001)